Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody

被引:31
作者
Tanaka, M
Tanaka, K
Tokiguchi, S
Shinozawa, K
Tsuji, S
机构
[1] Natl W Niigata Cent Hosp, Dept Neurol, Niigata 9502085, Japan
[2] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan
[3] Ojiya Gen Hosp, Dept Neurol, Ojiya, Japan
[4] Saiseikai Kawaguchi Gen Hosp, Dept Neurol, Kawaguchi, Japan
[5] Natl W Niigata Cent Hosp, Clin Res Ctr, Niigata 9502085, Japan
关键词
paraneoplastic syndrome; anti-Yo antibody; cerebellar ataxia; cytotoxic T cells; reverse immunogenetics;
D O I
10.1016/S0022-510X(99)00163-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Anti-Yo antibodies are present in the sera and cerebrospinal fluid of some patients with paraneoplastic cerebellar degeneration (PCD), but there is no evidence that the presence of anti-Yo antibodies causes the Purkinje cell loss seen in PCD patients. We examined the level of cytotoxic T lymphocyte (CTL) activity against a nine-amino acid peptide of the Yo protein using the Human Leukocyte Antigen(HLA-) based approach called reverse immunogenetics. Mononuclear cells (MNCs) were isolated from the peripheral venous blood and fibroblasts were obtained from the skin of three patients with PCD with anti-Yo antibody. After activating the MNCs of the three patients with the peptide, it showed CTL activity against the Yo protein peptide expressed on autologous fibroblasts. Therefore, CTLs may be involved in the loss of Purkinje cells in PCD. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:28 / 31
页数:4
相关论文
共 14 条
  • [1] Tumor-specific killer cells in paraneoplastic cerebellar degeneration
    Albert, ML
    Darnell, JC
    Bender, A
    Francisco, LM
    Bhardwaj, N
    Darnell, RB
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1321 - 1324
  • [2] Reverse immunogenetics: From HLA-disease associations to vaccine candidates
    Davenport, MP
    Hill, AVS
    [J]. MOLECULAR MEDICINE TODAY, 1996, 2 (01): : 38 - 45
  • [3] Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system
    Giometto, B
    Marchiori, GC
    Nicolao, P
    Scaravilli, T
    Lion, A
    Bardin, PG
    Tavolato, B
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (06) : 468 - 474
  • [4] CHANGES IN LAK SUSCEPTIBILITY OF TUMOR-CELLS AS THEIR MHC CLASS-I ANTIGEN EXPRESSION LEVELS REGENERATE AFTER TREATMENT AT PH-3.0
    HARIDAS, V
    SAXENA, RK
    [J]. IMMUNOLOGY LETTERS, 1995, 44 (01) : 7 - 11
  • [5] JAECKLE KA, 1986, NEUROLOGY, V36, P332
  • [6] KUBO RT, 1994, J IMMUNOL, V152, P3913
  • [7] POSNER JB, 1995, NEUROLOGIC COMPLICAT, P353
  • [8] MCH LIGANDS AND PEPTIDE MOTIFS - FIRST LISTING
    RAMMENSEE, HG
    FRIEDE, T
    STEVANOVIC, S
    [J]. IMMUNOGENETICS, 1995, 41 (04) : 178 - 228
  • [9] Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway
    RensingEhl, A
    Malipiero, U
    Irmler, M
    Tschopp, J
    Constam, D
    Fontana, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) : 2271 - 2274
  • [10] PASSIVE TRANSFER AND ACTIVE IMMUNIZATION WITH THE RECOMBINANT LEUCINE-ZIPPER (YO) PROTEIN AS AN ATTEMPT TO ESTABLISH AN ANIMAL-MODEL OF PARANEOPLASTIC CEREBELLAR DEGENERATION
    TANAKA, K
    TANAKA, M
    ONODERA, O
    IGARASHI, S
    MIYATAKE, T
    TSUJI, S
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 127 (02) : 153 - 158